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Noradrenaline r l~se from rat brain cortical synaptosom~.'s permeabillzed with streptolysin O can be trie~ered by/.tM concentrations of free Ca 2÷. 
This process was inhibited within minutes by tetanus toxin and its isolated light chain, but not by its heavy chain. The data demonstrate that the 
effect of tetanus toxin on NA release frem purified synaptosomes is caused by the intraterminal ction of its light chain. 
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1. INTRODUCTION 
Tetanus toxin (TeTx), is a highly neurotoxic protein, 
which preferentially blocks neurotransmitter release 
frora neurons of the central nervous ystem (cf. [1-3]). 
It is synthesized by Clostridium tetani and consists of 
disulphide-linked heavy (100 kDa) and light chains (50 
kDa) (of. [3]) [4,5]. Ia contrast o the intact toxin~ the 
individual chains alone lack toxicity in vice [6,7]. 
When directly injected into the eytosol, TeTx inhibits 
exocytosis from adrenal chromaffin cells as revealed by 
cell capacitance measurements [8]. Also, in permeabil- 
ized adrenal chromaffin cells, pheochromocytoma cells 
(PCI2 cells) [9-11] and neuroseeretosomes from the 
posterior pituitary gland [I2], TeTx turned out to be a 
potent inhibitor of noradrenaline (NA) and vasopressin 
release. In addition it has been shown that TeTx is more 
effective in these cells in the presence of a reducing 
agent, which causes chain separation [9,10,12]. Indeed, 
the ability of TeTx to inhibit release of cateeholamines 
[10,13] and vasopressin [12] was found to be confined 
to the light chain subunit of this protein. Microinjection 
of TeTx and its isolated chains or of mRNA encoding 
lbr TeTx light chain in ganglia of Aplysfa californica, 
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allowed to extend these findings to invertebrate n uron~ 
[14,15]. In contrast, amylase release from streptolysin O 
(SLO)-permeabilized pancreatic acinar cells is insensi- 
tive to TeTx and its light chains [16]. 
Taken together the available data suggest that exocy- 
tosis from endocrine cells, endocrine nerve endings and 
invertebrate neurons but not from exocrine cells is 
blocked by the light chain of TeTx. However, the intra- 
cellular effect of TeTx on neurotransmitter r lease from 
neurons of the mammalian central nervous ystem, the 
targets in TeTx-induced neuroparalytie diseases, was 
not studied to date. 
SLO-permeabilized synaptosomes release NA upon 
addition of Ca 2~' in/zM concentrations [17-19]. This 
preparation is suitable to introduce macromolecules 
into the presynaptic terminal, since antibodies against 
the intrasynaptosomal protein kinase C substrate B-50 
inhibit Ca2÷-induced NA release as well as B-50 phos- 
phorylation [18,19]. In the present study we used this 
preparation to study the intraterminal effect of TeTx 
and its isolated chains on Ca2*-induced NA release. 
2. MATERIALS AND METHODS 
')-.1. Materials 
Tetanus toxin was separated into its heavy and light chains by 
isoeleetrie focusing in a sucrose gradient with ampholyte under educ- 
ing conditions in 2 mol/l urea [20]. Before use, all toxin preparations 
were dialyzed against the following buffer: 139 mM potassium gluta- 
mate, 20 mM PIPES, 5 mM EGTA, 1 mM MgCI2, pH 6.5, 
L.[7,8.~H]noradrenaline (specific activity 34 CUmmol) was pur- 
ch~ed, from Amersham (Back!ngho.m.sh!re, UK). Per¢oll was ob- 
tained from Pharmaeia (Uppsala, Sweden), ATP from Boehringer 
(Mannheim, Germany), SLO from Wellcome (Weesp, The Nether- 
lands), EGTA and BSA from Sigma (St. Louis, USA). 
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2.2. Methoda 
2.2.1. [~H]noradrenaline r lease from SLO-permeabilized synap- 
tOSOlrtes 
Synaptosomes were prepared from cerebrocortex of male Wistar 
rats (100-120 g) as de.~cribed [21]. They were incubated in oxyBenated 
buffer A (mM: 123 NaCI, 5 KCl, 2 CaCl2, 2 MgCI2, 1.15 NaH_~PO4, 
20 PIPES, 5.6 n-(+)-$1ucose, pH 6,8), labdlcd with [~H]NA (2.5/aCi/ 
mg synaptosomal protein) and washed as described earlier 118], 
Synaptosomes (final concentration: 0.17 mg/ml) were permeabilized 
with 0.3 IU/ml SLO in buffer A (without CaCI2 and M8C12) in the 
presence of 1 mg/ml BSA, 2 mM ATP, 10 mM EGTA, 2 mM free 
Mg 2+, the indicated concentration of Ca 2. and the TeTx preparation 
to be tested i've' 5 minutc~ at 37°C (water bath). Ca:+/EOTA buffers 
were calculated and prepared as described [22]. 
Incubations were stopped by centrifugation for 25 s at 10,00O ×g. 
[3H]NA release was determined by liquid scintillation counting of the 
radioactivity inthe supernatant. NA release is expre~ed as percentage 
of total [~H]NA incorporated. 
2.2.2. Other determinations 
Protein concentrations ware determined according to [23] using 
BSA as a standard. Statistical analysis was performed with a two- 
tailed Student'5 t-test. A value o fP  < 0.05 was considered to be sisnif- 
ieant. 
3. RESULTS 
Increasing the free Ca 2. concentration from 10 -8 M 
to 10 -5 M induced the release of 12% of total [3H]NA 
incorporated by SLO-permeabilized synaptosomes. 
This Ca~-÷-induced [3H]NA release was inhibited by ad- 
dition of TeTx light chain within 5 minutes of incuba- 
tion in a dose-dependent manner (Fig. 1, ICs0 about 300 
nM). Incubation with 100, 300 and 1000 nM light chain 
led to 9%, 30% and 48% inhibition of Ca2*-indueed NA 
release, respectively. The basal [3H]NA release (in the 
presence of 10 "~ M Ca 2*) was not significantly affected 
up to 300 nM LC. 1000 nM light chain caused a slight 
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Fig. 1, Effect of TeTx light chain on [~H]NA release from SLO- 
permeabilized synaptosomes. Synaptosom~ were permeabilized with 
0.3 IUhnl SLO in the presence of 10-" M Ca 2. (open circles) or 10 -~ 
M Ca 2÷ (filled circles) for S minutes at 37ec. The indicated concentra- 
tions of TeT~ !igh t. chain were present hroughout he experiment 
(abscissa). [~HINA release was measured as described (see Methods) 
and is expressed as percentaBe of total [~I-I]NA incorporated (ordi- 
nate). Data are means + SEM of 12-24 determinations obtained from 
four independent experiments. 
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Fig. 2. Effect of TeTx and its isolated light and heavy chain on [~H]NA 
release from SLO.permeabilized synaptosomes. Synaptosomes were 
permeabilized with 0.3 IU/mi SLO in the presence of  10 -~ M Ca 2° 
(open bars) or 10 -~ M Ca"* (filled bars) for 5 minutes at 370C. 
Throughout the experiment, either no toxin (C) or TeTx, its light (L) 
or heavy chains (H) were present each at 1000 nM. [~H]NA relea.~ is 
expressed as percentage oftotal [3H]NA incorporated (ordinate). Data 
are means - SEM of 6-18 determinations obtained from three inde- 
pendent experiments. 
chain form) was less active when compared to the effect 
of its light chain (Fig. 2). The inhibitory effect of TeTx 
and its light chain was abolished by boiling (not shown). 
Isolated TeTx heavy chains lacked any effect (Fig. 2). 
4. DISCUSSION 
A three step-model for the action ofclostridiai neuro- 
toxins such as TeTx and botulinum A toxin (BeNT/A) 
has been suggested (cf. [3,24,25]). The three steps in- 
volve (i) binding of the toxins to the cell surface via the 
heavy chain, (it) internalization and transfer to the cyto- 
plasm and (iii) inhibition of a Ca2*-dependent step in 
exocytosis by the light chain. Using intact cell prepara- 
tions, the intracellular action of dostridial neurotoxins 
could not directly be investigated. The direct intracellu- 
lar application of the toxins and their fragments in nor- 
mal or neoplastic chromaffin cells via a patch clamp 
pipette [8] or by permeabilization of the plasma mem- 
brane [9,10,13,26--29] allowed to demonstrate that tox- 
icity is confined to the light chains of both, TeTx and 
BoNT/A and that the toxins act at a step downstream 
of the action of Ca 2+ during exoeytosis. 
In this study we investigated for the first time the 
intraterminal effects of  TeTx in endings from the mam- 
malian central nervous system. We used a SLO-permea- 
bilized synaptosome preparation, which has been 
shown to release NA in a Ca2*-dependent manner [17- 
19]. With this preparation, which is suitable to intro- 
duce macromoleeules without affecting the release ma- 
chinery [19,30], we show that the TeTx light chain inhib- 
its Ca2÷-induced NA release. The inhibitory effect of the 
light chain is observed within 5 minutes. Since signifi- 
cant permeabilization with SLO can be observed after 
about I minute [18] and NA release is complete in a~out 
3 minutes (Hens and De Graan, unpublished), the effect 
of the light chain probably occurs within 3 minutes. 
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The results are consistent with the observed short 
time required for the action of TeTx light chain in per- 
meabilized neurosecretosomes from the posterior pitui- 
tary gland [12] and are indicative for a fast intracellular 
action of the TeTx light chain. Intact TeTx was less 
effective in permeabilized synaptosomes than the iso- 
lated light chain. This may indicate that chain separa- 
tion, which presumably is an important process during 
TeTx and BoNT/A activation [9,10,12,26,31], by en- 
dogenous systems [32], is probably not completed 
within the 5 minutes ot' incubation. 
In contrast o the light chain, the heavy chain alone 
did not inhibit [3H]NA release from SLO-permeabilized 
synaptosomes. Similarly, intracellular application of 
TeTx light chains but not of heavy chains was reported 
to inhibit vasopressin release from neurosecretosomes 
of the posterior pituitary gland [12], acetylcholine from 
ganglia ofAplysia cafifornica [14] and NA from adrenal 
ehromaffin cells [10,13]. 
The above-mentioned results show similarities with 
those reported for BoNT/A, which is in many respects 
very similar to TeTx (el. [1-3]). In normal or neoplastic 
chromaffin cells as well as in neurohypophyseal nerve 
endings, only the light chain, but not the heavy chain 
of BoNT/A inhibits exocytosis [27-29,31]. However, 
when injected into Aplysia neurons, the isolated light 
chain of BoNWA, has no effect. In these neurons both 
the heavy and the light chains must be simultaneously 
present to inhibit transmitter release [33,34]. The intra- 
cellular effect of BoNT/A and its isolated chains on 
synapses of the central nervous ystem has yet not been 
investigated. It will be interesting to see, whether the 
light chain alone will have any effect in this system or 
whether, in analogy to invertebrate neurons, the pres- 
ence of the heavy chain is required. 
In summary, our data show that the light chain of 
tetanus toxin alone inhibits transmitter release from 
permeabilized rat brain synaptosomes. They support 
previous investigations carried out with adrenal chro- 
mar'fin cells, nerve endings from the posterior pituitary 
gland and invertebrate ganglia and extend them to neu- 
rons of the central nervous ystma being structures di- 
rectly involved in tetanus toxin-induced disease. 
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